<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cancer - Leukemia on VitaminDWiki</title><link>/tags/cancer---leukemia.html</link><description>Recent content in Cancer - Leukemia on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Wed, 19 Jul 2023 00:00:00 +0000</lastBuildDate><atom:link href="/tags/cancer---leukemia/index.xml" rel="self" type="application/rss+xml"/><item><title>13 Cancers are helped by Vitamin D – Biobank</title><link>/posts/13-cancers-are-helped-by-vitamin-d-biobank.html</link><pubDate>Wed, 19 Jul 2023 00:00:00 +0000</pubDate><guid>/posts/13-cancers-are-helped-by-vitamin-d-biobank.html</guid><description>&lt;h4 id="associations-of-25-hydroxyvitamin-d-status-and-vitamin-d-supplementation-use-with-mortality-due-to-18-frequent-cancer-types-in-the-uk-biobank-cohort">Associations of 25-hydroxyvitamin D status and vitamin D supplementation use with mortality due to 18 frequent cancer types in the UK Biobank cohort&lt;/h4>
&lt;p>European Journal of Cancer :July 17, 2023 DOI:https://doi.org/10.1016/j.ejca.2023.113241 PDF is behind a paywall&lt;/p>
&lt;p>Sha Sha, Li-Ju Chen, PhD, Hermann Brenner, Prof. MD. Ben Schöttker, PhD&lt;/p>
&lt;p>&lt;strong>Reduced Cancer for people reporting taking &lt;span style="color:#00F;">any&lt;/span> amount of Vitamin D&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cancer-users-vs-non-users.jpg" alt="image" width="600">
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Deaths due to 18 specific cancers were the outcomes of interest in the UK Biobank.&lt;/p></description></item><item><title>Cancer in children (Leukemia) more likely to recur if 20-30 ng of vitamin D</title><link>/posts/cancer-in-children-leukemia-more-likely-to-recur-if-20-30-ng-of-vitamin-d.html</link><pubDate>Fri, 25 Nov 2022 00:00:00 +0000</pubDate><guid>/posts/cancer-in-children-leukemia-more-likely-to-recur-if-20-30-ng-of-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-abnormalities-of-children-with-recurrence-of-malignancy-and-comparison-with-newly-diagnosed-patients">Vitamin D abnormalities of children with recurrence of malignancy and comparison with newly diagnosed patients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-health-problems-recur-if-low-vitamin-d">Some health problems recur if low vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#note-some-health-problems-protect-themselves-by-deactivating-the-vitamin-d-receptor">Note: Some health problems protect themselves by deactivating the Vitamin D Receptor&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-in-vitamindwiki">See also in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-abnormalities-of-children-with-recurrence-of-malignancy-and-comparison-with-newly-diagnosed-patients">Vitamin D abnormalities of children with recurrence of malignancy and comparison with newly diagnosed patients&lt;/h4>
&lt;p>Caspian J Intern Med . 2022 Fall;13(4):735-740. &lt;a href="https://doi.org/10.22088/cjim.13.4.735.">doi: 10.22088/cjim.13.4.735.&lt;/a>&lt;/p>
&lt;p>Nahid Reisi 1 , Azar Mirzaei 2 , Alireza Moafi 1 , Pouran Raeissi 3 , Maryam Naghdhassani 4&lt;/p></description></item><item><title>Poor chemotherapy results if low vitamin D (leukemia in this case)</title><link>/posts/poor-chemotherapy-results-if-low-vitamin-d-leukemia-in-this-case.html</link><pubDate>Wed, 17 Aug 2022 00:00:00 +0000</pubDate><guid>/posts/poor-chemotherapy-results-if-low-vitamin-d-leukemia-in-this-case.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#preinduction-serum-vitamin-d3-levels-and-induction-chemotherapy-remission-rates-in-patients-with-acute-leukemia">Preinduction Serum Vitamin D3 Levels and Induction Chemotherapy Remission Rates in Patients with Acute Leukemia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-in-vitamindwiki">See also in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#warning-vitamin-d-can-increase-chemo-potency---possible-death-if-chemo-dose-is-not-reduced">Warning: Vitamin D can increase Chemo potency - possible death if chemo dose is not reduced&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="preinduction-serum-vitamin-d3-levels-and-induction-chemotherapy-remission-rates-in-patients-with-acute-leukemia">Preinduction Serum Vitamin D3 Levels and Induction Chemotherapy Remission Rates in Patients with Acute Leukemia&lt;/h4>
&lt;p>Nutrition and Cancer – &lt;a href="https://doi.org/10.1080/01635581.2022.2077389">https://doi.org/10.1080/01635581.2022.2077389&lt;/a> PDF behind paywall&lt;/p>
&lt;p>Shweta Maurya. Anil Kumar Tripathi, Shailendra Prasad Verma&lt;/p>
&lt;p>Vitamin D deficiency(&amp;lt;20 ng/mL) is a common condition, associated with an inferior prognosis in some cancers. However, the prognostic significance of vitamin D deficiency in acute leukemia is largely unknown. The present study aimed to assess the baseline status of vitamin D &lt;span>[25-(OH) D3]&lt;/span> and find its association with induction remission rate and mortality using standard chemotherapy in patients with acute leukemia. In this prospective observational study, blood samples were collected from 73 newly diagnosed patients before starting induction chemotherapy to measure serum vitamin D &lt;span>[25(OH)D]&lt;/span> levels along with routine investigations.44/73 (60.3%) patients were acute lymphoblastic leukemia (ALL), and 29/77 (39.7%) were acute myeloid leukemia (AML) patients. Descriptive statistics and frequency distribution were used in SPSS software, and Pearson’s chi-squared test compared the categorical variables. Post-induction remission status (complete and incomplete remission) and induction-related mortality were correlated with vitamin D levels. 44/73 patients (60.3%) included in this study were males, and the remaining were females. The mean age of the participants was 30.32 ± 14.95 years. The mean serum vitamin D level in the cohort was 15.74 ± 28.14 ng/mL. Vitamin D deficiency was observed in 59/73 (80.8%) patients, whereas 14/73 (19.2%) had normal levels (≥20ng/mL) of the vitamin. Vitamin D deficiency is common among acute leukemia patients. Herein, we observed that &lt;strong>low vitamin D level is associated with higher rates of incomplete remission in acute leukemia patients (P = 0.016)&lt;/strong> . Vitamin D deficiency is common among acute leukemia patients and is associated with poor short-term outcomes.&lt;/p></description></item><item><title>Relapses of Acute Lymphoblastic Leukemia (ALL) – 1 in 5 are due to genes mutated by chemotherapy</title><link>/posts/relapses-of-acute-lymphoblastic-leukemia-all-1-in-5-are-due-to-genes-mutated-by-chemotherapy.html</link><pubDate>Sun, 10 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/relapses-of-acute-lymphoblastic-leukemia-all-1-in-5-are-due-to-genes-mutated-by-chemotherapy.html</guid><description>&lt;h4 id="naturalhealth365httpswwwnaturalhealth365comchemotherapy-leukemia-3182html">&lt;a href="https://www.naturalhealth365.com/chemotherapy-leukemia-3182.html">NaturalHealth365&lt;/a>&lt;/h4>
&lt;p>“Greater than 3,000: that’s how many new cases of acute lymphoblastic leukemia (ALL) are diagnosed every year in the United States. According to the Centers for Disease Control and Prevention, ALL is responsible for 20% of all cancers in people younger than 20 years old. And, sadly, the Dana-Farber Cancer Institute finds that up to 1 in 5 kids who undergo chemotherapy for ALL will relapse – even if they initially receive a complete remission of the cancer.”&lt;/p></description></item><item><title>Acute Myeloid Leukemia (a form of bone cancer) better if more than 20 ng of vitamin D</title><link>/posts/acute-myeloid-leukemia-a-form-of-bone-cancer-better-if-more-than-20-ng-of-vitamin-d.html</link><pubDate>Thu, 06 Jul 2017 00:00:00 +0000</pubDate><guid>/posts/acute-myeloid-leukemia-a-form-of-bone-cancer-better-if-more-than-20-ng-of-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#high-prevalence-of-vitamin-d-deficiency-in-newly-diagnosed-acute-myeloid-leukemia-patients-and-its-adverse-outcome---2017">High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome - 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#application-of-vitamin-d-and-vitamin-d-analogs-in-acute-myelogenous-leukemia---june-2017">Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. - June 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#aml--vitamin-d-and-vitamin-d-receptor---2014">AML : Vitamin D and Vitamin D Receptor - 2014&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="high-prevalence-of-vitamin-d-deficiency-in-newly-diagnosed-acute-myeloid-leukemia-patients-and-its-adverse-outcome---2017">High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome - 2017&lt;/h4>
&lt;p>International Journal of Hematology-Oncology and Stem Cell Research 2017. 11(3):209-216.&lt;/p></description></item><item><title>Vitamin D in haematological disorders and malignancies</title><link>/posts/vitamin-d-in-haematological-disorders-and-malignancies.html</link><pubDate>Sat, 15 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-in-haematological-disorders-and-malignancies.html</guid><description>&lt;p>European Journal of haematology. Accepted manuscript online: 15 October 2016. DOI: 10.1111/ejh.12818V&lt;/p>
&lt;p>Paige M. Kulling, Kristine C. Olson, Thomas L. Olson, David J. Feith, Thomas P. Loughran Jr&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=haematological+OR+haematology&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com%20">Search VitaminDWiki for haematological OR haematology&lt;/a> 49 items as of Oct 2016&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=anemia&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for ANEMIA&lt;/a> 269 items as of Oct 2016&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/sickle-cell-vitamin-d-deficiency-corrected-with-160-k-iu-loading-dose">Sickle cell Vitamin D deficiency corrected with 160 K IU loading dose – July 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/iron-deficiency-is-a-cause-of-vitamin-d-deficiency">Iron deficiency is a cause of Vitamin D deficiency&lt;/a>&lt;/p></description></item><item><title>Less Leukemia where there is more UVB (Vitamin D, 172 countries)</title><link>/posts/less-leukemia-where-there-is-more-uvb-vitamin-d-172-countries.html</link><pubDate>Sat, 05 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/less-leukemia-where-there-is-more-uvb-vitamin-d-172-countries.html</guid><description>&lt;h4 id="low-cloud-cover-adjusted-ultraviolet-b-irradiance-is-associated-with-high-incidence-rates-of-leukemia-study-of-172-countries">Low Cloud Cover-Adjusted Ultraviolet B Irradiance Is Associated with High Incidence Rates of Leukemia: Study of 172 Countries.&lt;/h4>
&lt;p>PLoS One. 2015 Dec 4;10(12):e0144308. &lt;a href="https://doi.org/10.1371/journal.pone.0144308.">doi: 10.1371/journal.pone.0144308.&lt;/a>&lt;/p>
&lt;p>Cuomo RE1,2, Garland CF3, Gorham ED3, Mohr SB3.&lt;/p>
&lt;p>1Division of Global Health, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California, United States of America.&lt;/p>
&lt;p>2Graduate School of Public Health, San Diego State University, San Diego, California, United States of America.&lt;/p></description></item><item><title>Lymphoma, leukemia etc, survival poor if low vitamin D – meta-analysis</title><link>/posts/lymphoma-leukemia-etc-survival-poor-if-low-vitamin-d-meta-analysis.html</link><pubDate>Wed, 15 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/lymphoma-leukemia-etc-survival-poor-if-low-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-levels-and-prognosis-in-hematological-malignancies-a-systematic-review-and-meta-analysis">Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis.&lt;/h4>
&lt;p>Cell Physiol Biochem. 2015 Mar 27;35(5):1999-2005. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Wang W1, Li G, He X, Gao J, Wang R, Wang Y, Zhao W.&lt;/p>
&lt;p>1Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao, China.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;p>Hazard Ratios for surviving hematological malignancies&lt;/p>
&lt;p>   Such as lymphoma and leukemia&lt;/p>
&lt;p>Low vitamin D (level undefined in abstract)&lt;/p>
&lt;p>Overall survival: 1.85&lt;/p></description></item><item><title>Chronic lymphocytic leukaemia and Vitamin D and Dr. Gillie</title><link>/posts/chronic-lymphocytic-leukaemia-and-vitamin-d-and-dr-gillie.html</link><pubDate>Mon, 18 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/chronic-lymphocytic-leukaemia-and-vitamin-d-and-dr-gillie.html</guid><description>&lt;h3 id="a-suntan-is-not-only-healthy-it-can-be-life-savinghttpwwwtelegraphcoukhealth11040119a-suntan-is-not-only-healthy-it-can-be-life-savinghtml--telegraph-uk">&lt;a href="http://www.telegraph.co.uk/health/11040119/A-suntan-is-not-only-healthy-it-can-be-life-saving.html">A suntan is not only healthy, it can be life-saving&lt;/a> Telegraph UK&lt;/h3>
&lt;p>Oliver Gillie, who is battling leukemia, explains why he blames the disease on a lack of exposure to the sun.&lt;/p>
&lt;p>&lt;strong>As a science writer he has written extensively on health and vitamin D&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Summary and excerpts from the Telegraph article which he wrote&lt;/strong>&lt;/p>
&lt;p>Diagnosed with CLL in 2012&lt;/p>
&lt;p>Had heparin injections, steroids, and infusions of Rituximab (£1,222 per dose)&lt;/p></description></item><item><title>Chemo reduced leukemia patients vitamin D levels</title><link>/posts/chemo-reduced-leukemia-patients-vitamin-d-levels.html</link><pubDate>Fri, 20 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/chemo-reduced-leukemia-patients-vitamin-d-levels.html</guid><description>&lt;h4 id="vitamin-d-levels-in-patients-of-acute-leukemia-before-and-after-remission-induction-therapy">Vitamin D levels in patients of acute leukemia before and after remission-induction therapy.&lt;/h4>
&lt;p>Pak J Med Sci. 2013 Jan;29(1):10-4. &lt;a href="https://doi.org/10.12669/pjms.291.2764.">doi: 10.12669/pjms.291.2764.&lt;/a>&lt;/p>
&lt;p>Naz A1, N Qureshi R2, S Shamsi T3, Mahboob T4.&lt;/p>
&lt;p>Objectives: To determine the levels of 25-hydroxyvitamin &lt;span>[25(OH)D3]&lt;/span> in patients with acute leukemia and the effect of remission-induction chemotherapy.&lt;/p>
&lt;p>Methodology: This study was case control, all newly diagnosed patients of acute leukemia between the age of one to sixty years and residents of Pakistan were enrolled and evaluated. Those who were unwilling or unable to provide written informed consent were excluded. All selected patients (n=86) were grouped in to acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). AML was further categorized as A1 before remission-induction (n=17) and B1 after remission induction (n=13), ALL was further categorized as A2 before remission-induction (n=31) and B2 after remission induction (n=25). The 25-hydroxyvitamin &lt;span>[25(OH)D3]&lt;/span> levels were measured in the sera of all patients (before and after remission-induction) by one step delayed chemiluminescent micro particle immunoassay (CMIA).We compared 25(OH)D3 levels in all patients before and after the remission-induction chemotherapy.&lt;/p></description></item><item><title>Molecular Link between Vitamin D and Cancer Prevention</title><link>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</link><pubDate>Wed, 02 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</guid><description>&lt;p>Nutrients 2013, 5(10), 3993-4021; doi:10.3390/nu5103993&lt;/p>
&lt;p>Meis Moukayed 1email and William B. Grant 2,* email&lt;/p>
&lt;p>1 School of Arts and Sciences, American University in Dubai, P. O. Box 28282, Dubai, UAE&lt;/p>
&lt;p>2 Sunlight, Nutrition, and Health Research Center, San Francisco, CA 94164-1603, USA&lt;/p>
&lt;ul>
&lt;li>Author to whom correspondence should be addressed.&lt;/li>
&lt;/ul>
&lt;p>Received: 7 August 2013; in revised form: 11 September 2013 / Accepted: 18 September 2013 / Published: 30 September 2013&lt;/p>
&lt;p>(This article belongs to the Special Issue Vitamin D and Human Health)&lt;/p></description></item><item><title>Cancer - Leukemia</title><link>/posts/cancer-leukemia.html</link><pubDate>Sun, 11 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/cancer-leukemia.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#fda-approved-gene-based-treatment-of-leukemia--475000---aug-2017">FDA approved gene-based treatment of Leukemia $475,000 - Aug 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-insufficiency-might-aid-in-predicting-lymphocytic-leukemia--july-2024">Vitamin D insufficiency might aid in predicting lymphocytic leukemia – July 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="fda-approved-gene-based-treatment-of-leukemia--475000---aug-2017">FDA approved gene-based treatment of Leukemia $475,000 - Aug 2017&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.nytimes.com/2017/08/30/health/gene-therapy-cancer.html">New York Times&lt;/a>&lt;/strong> *&amp;quot; . . .can have life-threatening side effects, including dangerous drops in blood pressure&amp;quot;&lt;/p>
&lt;hr>
&lt;h4 id="vitamin-d-insufficiency-might-aid-in-predicting-lymphocytic-leukemia--july-2024">Vitamin D insufficiency might aid in predicting lymphocytic leukemia – July 2024&lt;/h4>
&lt;p>&lt;strong>Vitamin D insufficiency in CLL: a modifiable prognostic factor?&lt;/strong>&lt;/p></description></item><item><title>Overview Leukemia and Vitamin D</title><link>/posts/overview-leukemia-and-vitamin-d.html</link><pubDate>Sun, 11 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/overview-leukemia-and-vitamin-d.html</guid><description>&lt;h4 id="100000-iu-vitamin-d-helped-bones-after-leukemia-chemo-treatments---rct-2017">100,000 IU Vitamin D helped bones after Leukemia Chemo Treatments - RCT 2017&lt;/h4>
&lt;p>&lt;strong>A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia.&lt;/strong>&lt;/p>
&lt;p>Leuk Lymphoma. 2017 Oct;58(10):2370-2378. &lt;a href="https://doi.org/10.1080/10428194.2017.1289526.">doi: 10.1080/10428194.2017.1289526.&lt;/a> Epub 2017 Feb 20.&lt;/p>
&lt;p>Orgel E1,2, Mueske NM3, Sposto R1,2, Gilsanz V2,4, Wren TAL2,3, Freyer DR1,2, Butturini AM1,2, Mittelman SD2,5.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>I found it difficult to understand exactly when and how often the 100,000 IU was given&lt;/strong>&lt;/p></description></item><item><title>Vitamin D, Sunlight and Cancer Connection – Holick</title><link>/posts/vitamin-d-sunlight-and-cancer-connection-holick.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-sunlight-and-cancer-connection-holick.html</guid><description>&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.70-82 (13)&lt;/p>
&lt;p>Author: Michael F. Holick&lt;/p>
&lt;p>&lt;strong>PDF with ALL graphics is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;p>It has been more than 100 years when it was first appreciated that increased sun exposure reduced risk of dying of cancer. The most beneficial effect of sun exposure is the production of vitamin D in the skin. Recent evidence suggests that most cells in the body not only have a vitamin D receptor but also have the capacity to convert 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. Once formed 1,25-dihydroxyvitamin D can inhibit cellular proliferation, induce cellular maturation, inhibit angiogenesis and ultimately cause apoptosis to prevent malignancy. A multitude of studies have associated improved vitamin D status with decreased risk for developing several deadly cancers including colon, breast, pancreatic and ovarian cancers. Patients with cancer are at high risk for vitamin D deficiency. Sensible sun exposure, vitamin D fortification and vitamin D supplementation should be encouraged to improve the vitamin D status of children and adults not only for bone health but for reducing risk of developing and dying of cancer. The goal is to achieve a blood level of 25-hydroxyvitamin D of 40-60 ng/mL. This can be accomplished by children taking 600-1000 and adults 1500-2000 international units (IU) vitamin D daily from diet and supplements along with sensible sun exposure when the sun is capable of producing vitamin D in the skin.&lt;/p></description></item><item><title>Leukemia should be helped by vitamin D – Review</title><link>/posts/leukemia-should-be-helped-by-vitamin-d-review.html</link><pubDate>Tue, 04 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/leukemia-should-be-helped-by-vitamin-d-review.html</guid><description>&lt;h3 id="clinical-experience-using-vitamin-d-and-analogs-in-the-treatment-of-myelodysplasia-and-acute-myeloid-leukemia-a-review-of-the-literature">Clinical experience using vitamin d and analogs in the treatment of myelodysplasia and acute myeloid leukemia: a review of the literature.&lt;/h3>
&lt;p>Leuk Res Treatment. 2012;2012:125814. &lt;a href="https://doi.org/10.1155/2012/125814.">doi: 10.1155/2012/125814.&lt;/a> Epub 2012 Jul 30.&lt;/p>
&lt;p>Harrison JS, Bershadskiy A.&lt;/p>
&lt;p>Division of Hematology, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA ; The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA.&lt;/p></description></item><item><title>Cancers and Vitamin D Council</title><link>/posts/cancers-and-vitamin-d-council.html</link><pubDate>Wed, 07 Sep 2011 00:00:00 +0000</pubDate><guid>/posts/cancers-and-vitamin-d-council.html</guid><description/></item><item><title>Low UVB countries have higher leukemia rates</title><link>/posts/low-uvb-countries-have-higher-leukemia-rates.html</link><pubDate>Fri, 17 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/low-uvb-countries-have-higher-leukemia-rates.html</guid><description/></item><item><title>Chronic lymphocytic leukemia slowed by vitamin D - Mayo</title><link>/posts/chronic-lymphocytic-leukemia-slowed-by-vitamin-d-mayo.html</link><pubDate>Wed, 03 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/chronic-lymphocytic-leukemia-slowed-by-vitamin-d-mayo.html</guid><description>&lt;h1 id="2-minute-46-second-video-by-mayo-clinichttpwwwyoutubecomwatchvvoofljuxtgifeatureyoutube_gdata">&lt;a href="http://www.youtube.com/watch?v=VOOFljuXtgI&amp;amp;feature=youtube_gdata">2 minute 46 second Video by Mayo Clinic&lt;/a>&lt;/h1>
&lt;p>Researchers at Mayo Clinic have found a significant difference in cancer progression and death in chronic lymphocytic leukemia (CLL) patients who had sufficient vitamin D levels in their blood compared to those who didn’t.&lt;/p>
&lt;p>In the Mayo Clinic study, published online in the journal Blood, the researchers found that patients with &lt;strong>insufficient levels of vitamin D when their leukemia was diagnosed progressed much faster and were about twice as likely to die as were patients with adequate levels of vitamin D.&lt;/strong>&lt;/p></description></item></channel></rss>